Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias

Annals of Hematology · Published 2026-07-08 · DOI 10.1007/s00277-026-07159-x

Free full text

Authors (9)

Xiao Long, Xinyi Qin, Hui Ke, Li Tang, Yanfang Zhang, Hanqing Zeng, Jianchuan Deng, Yun Luo, Chun Cao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Long, X., Qin, X., Ke, H., et al. (2026). Single low-dose daratumumab enhances rituximab efficacy for sustained remission in treatment-refractory autoimmune cytopenias. Annals of Hematology. https://doi.org/10.1007/s00277-026-07159-x

Related articles